Study Debunks Use of Antidepressant Luvox as COVID Treatment
THURSDAY, Oct. 20, 2022 (HealthDay News) — A study testing drugs that are used for other conditions for their potential in treating COVID-19 has found that the antidepressant fluvoxamine (brand name Luvox) offered no benefit, at least at an initial smaller dose. Study participants took 50 mg of the medicationContinue Reading